Posttraumatic Stress Disorder and Adherence to Medications in Survivors of Strokes and Transient Ischemic Attacks

Background and Purpose— Posttraumatic stress disorder (PTSD) can be triggered by life-threatening medical events such as strokes and transient ischemic attacks (TIAs). Little is known regarding how PTSD triggered by medical events affects patients' adherence to medications. Methods— We surveyed 535 participants, age ≥40 years old, who had at least 1 stroke or TIA in the previous 5 years. PTSD was assessed using the PTSD Checklist-Specific for stroke; a score ≥50 on this scale is highly specific for PTSD diagnosis. Medication adherence was measured using the 8-item Morisky scale. Logistic regression was used to test whether PTSD after stroke/TIA was associated with increased risk of medication nonadherence. Covariates for adjusted analyses included sociodemographics, Charlson comorbidity index, modified Rankin Scale score, years since last stroke/TIA, and depression. Results— Eighteen percent of participants had likely PTSD (PTSD Checklist-Specific for stroke ≥50), and 41% were nonadherent to medications according to the Morisky scale. A greater proportion of participants with likely PTSD were nonadherent to medications than other participants (67% versus 35%, P<0.001). In the adjusted model, participants with likely PTSD were nearly 3 times more likely (relative risk, 2.7; 95% CI, 1.7–4.2) to be nonadherent compared with participants without PTSD (PTSD Checklist-Specific for stroke <25) even after controlling for depression, and there was a graded association between PTSD severity and medication nonadherence. Conclusion— PTSD is common after stroke/TIA. Patients who have PTSD after stroke or TIA are at increased risk for medication nonadherence.

[1]  M. Whooley,et al.  Post-traumatic stress disorder is associated with poor health behaviors: findings from the heart and soul study. , 2012, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[2]  Frank H. Galvan,et al.  Discrimination as a key mediator of the relationship between posttraumatic stress and HIV treatment adherence among African American men , 2012, Journal of Behavioral Medicine.

[3]  J. Schwartz,et al.  Posttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortality. , 2011, Journal of psychiatric research.

[4]  E. Peterson,et al.  Secondary preventive medication persistence and adherence 1 year after stroke , 2011, Neurology.

[5]  S. Southwick,et al.  Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study , 2011, The Lancet.

[6]  U. Schnyder,et al.  Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. , 2011, Journal of cardiology.

[7]  Ale Algra,et al.  Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke , 2011, The Lancet.

[8]  T. Bakas,et al.  Poststroke depression and treatment effects on functional outcomes , 2011, Neurology.

[9]  T. Kimbrell,et al.  Does PTSD impair cognition beyond the effect of trauma? , 2011, The Journal of neuropsychiatry and clinical neurosciences.

[10]  M. Woodward,et al.  Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis , 2010, The Annals of pharmacotherapy.

[11]  B. Löwe,et al.  The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. , 2010, General hospital psychiatry.

[12]  R. Yoash-Gantz,et al.  Relationship Between Processing Speed and Executive Functioning Performance Among OEF/OIF Veterans: Implications for Postdeployment Rehabilitation , 2009, The Journal of head trauma rehabilitation.

[13]  Marie Krousel-Wood,et al.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension. , 2009, The American journal of managed care.

[14]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[15]  I. Wilson,et al.  The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. , 2008, AIDS patient care and STDs.

[16]  Jamie L Banks,et al.  Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis , 2007, Stroke.

[17]  E. Halm,et al.  Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes , 2006, Journal of General Internal Medicine.

[18]  W. Chaplin,et al.  Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. , 2006, American heart journal.

[19]  R. Spitzer,et al.  Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients , 2006, Journal of General Internal Medicine.

[20]  J. Gorman,et al.  Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. , 2006, Psychosomatics.

[21]  J. Bogousslavsky,et al.  Chronic posttraumatic stress symptoms after nonsevere stroke , 2006, Neurology.

[22]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[23]  N. Sayer,et al.  PTSD and Treatment Adherence: The Role of Health Beliefs , 2005, The Journal of nervous and mental disease.

[24]  Joseph A Boscarino,et al.  Posttraumatic Stress Disorder and Physical Illness: Results from Clinical and Epidemiologic Studies , 2004, Annals of the New York Academy of Sciences.

[25]  R. Yehuda,et al.  Posttraumatic Stress, Nonadherence, and Adverse Outcome in Survivors of a Myocardial Infarction , 2004, Psychosomatic medicine.

[26]  Xiaonan Xue,et al.  Estimating the relative risk in cohort studies and clinical trials of common outcomes. , 2003, American journal of epidemiology.

[27]  N. Tarrier,et al.  Posttraumatic stress disorder following medical illness and treatment. , 2003, Clinical psychology review.

[28]  Timothy W. Cooke,et al.  Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. , 2002, Stroke.

[29]  U. Schulz,et al.  Improving the Assessment of Outcomes in Stroke: Use of a Structured Interview to Assign Grades on the Modified Rankin Scale , 2002, Stroke.

[30]  R. G. Hoffman,et al.  The impact of PTSD on treatment adherence in persons with HIV infection. , 2001, General hospital psychiatry.

[31]  A. Rudnick,et al.  A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI). , 2001, General hospital psychiatry.

[32]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[33]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[34]  D. Clark,et al.  A cognitive model of posttraumatic stress disorder. , 2000, Behaviour research and therapy.

[35]  J. Fairbank,et al.  Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder. , 1998, The American journal of psychiatry.

[36]  T. W. Miller,et al.  Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD Checklist-Civilian Version (PCL-C) as a screening instrument. , 1998, Journal of consulting and clinical psychology.

[37]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.